naringenin and Carcinoma, Lewis Lung

naringenin has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Du, G; Han, X; Jin, L; Liang, W; Song, Z; Zhang, H	1

Other Studies

1 other study(ies) available for naringenin and Carcinoma, Lewis Lung

Article	Year
Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis. Cancer research, 2009, Apr-01, Volume: 69, Issue:7 Topics: Animals; Bleomycin; Carcinoma, Lewis Lung; Cell Line, Tumor; Down-Regulation; Female; Flavanones; Forkhead Transcription Factors; Immunologic Factors; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pulmonary Fibrosis; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1	2009

Article

Year

Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis.

Cancer research, 2009, Apr-01, Volume: 69, Issue:7

Topics: Animals; Bleomycin; Carcinoma, Lewis Lung; Cell Line, Tumor; Down-Regulation; Female; Flavanones; Forkhead Transcription Factors; Immunologic Factors; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pulmonary Fibrosis; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1

2009